| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |